Literature DB >> 28838672

Omics of Prion Diseases.

Silvia Vanni1.   

Abstract

Prion diseases are unique neurodegenerative pathologies that can occur with sporadic, genetic, and acquired etiologies. Human and animal prion diseases can be recapitulated in laboratory animals with good reproducibility providing highly controlled models for studying molecular mechanisms of neurodegeneration. In this chapter the overall area of omics research in prion diseases is described. The term omics includes all fields of studies that employ a comprehensive, unbiased, and high-throughput approach to areas of research such as functional genomics, transcriptomics, and proteomics. These kind of approaches can be extremely helpful in identifying disease susceptibility factors and pathways that are dysregulated upon the onset and the progression of the disease. Herein, the most important research about the various forms of prion pathologies in human and in models of prion diseases in animals is presented and discussed.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animals and human prion diseases; GWAS; Genomics; Microarray; Sequencing; Transcriptomics

Mesh:

Year:  2017        PMID: 28838672     DOI: 10.1016/bs.pmbts.2017.05.004

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  3 in total

1.  Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.

Authors:  Na Li; Huanni Li; Ya Wang; Lanqin Cao; Xianquan Zhan
Journal:  EPMA J       Date:  2020-10-10       Impact factor: 6.543

2.  Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance.

Authors:  Arianna Colini Baldeschi; Marco Zattoni; Silvia Vanni; Lea Nikolic; Chiara Ferracin; Giuseppina La Sala; Maria Summa; Rosalia Bertorelli; Sine Mandrup Bertozzi; Gabriele Giachin; Paolo Carloni; Maria Laura Bolognesi; Marco De Vivo; Giuseppe Legname
Journal:  J Med Chem       Date:  2022-06-30       Impact factor: 8.039

3.  BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers.

Authors:  Óscar López-Pérez; Marcos Bernal-Martín; Adelaida Hernaiz; Franc Llorens; Marina Betancor; Alicia Otero; Janne Markus Toivonen; Pilar Zaragoza; Inga Zerr; Juan José Badiola; Rosa Bolea; Inmaculada Martín-Burriel
Journal:  Biomolecules       Date:  2020-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.